Literature DB >> 20973726

How soon is now? The urgent need for randomized, controlled trials evaluating treatment of multidrug-resistant bacterial infection.

David L Paterson, Benjamin A Rogers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20973726     DOI: 10.1086/657243

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Simultaneous use of other antimicrobials may have influenced clinical outcomes.

Authors:  James A McKinnell; Samantha J Eells; Angel A Wang; Loren G Miller
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 2.  Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.

Authors:  Marin H Kollef; Yoav Golan; Scott T Micek; Andrew F Shorr; Marcos I Restrepo
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

3.  Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.

Authors:  Alessandro Russo; Simone Giuliano; Giancarlo Ceccarelli; Francesco Alessandri; Alessandra Giordano; Grazia Brunetti; Mario Venditti
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

4.  Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.

Authors:  Elisabeth E Donahey; Derek M Polly; J David Vega; Marshall Lyon; Javed Butler; Duc Nguyen; Ann Pekarek; Kristin Wittersheim; Patrick Kilgo; Christopher A Paciullo
Journal:  Tex Heart Inst J       Date:  2015-12-01

5.  Antibiotic prescription patterns at admission into a tertiary level intensive care unit in Northern India.

Authors:  Aparna Williams; Ashu S Mathai; Atul S Phillips
Journal:  J Pharm Bioallied Sci       Date:  2011-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.